StonvexLoading…
StonvexStonvexStonvexCore line items from GCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $2.44B | $2.33B | $2.32B | $2.38B |
Operating Income | $17.31M | $13.93M | $-13.46M | $93.24M |
Net Income | $13.27M | $-18.89M | $-16.83M | $71.92M |
EPS (Diluted) | $1.25 | $-1.74 | $-1.50 | $5.66 |
Total Assets | $1.39B | $1.34B | $1.33B | $1.46B |
Total Liabilities | $825.93M | $788.57M | $758.69M | $849.46M |
Cash & Equivalents | $105.41M | $34.01M | $35.16M | $47.99M |
Free Cash Flow OCF − CapEx | $83.71M | $46.75M | $34.49M | $-224.82M |
Shares Outstanding | 10.62M | 10.84M | 11.24M | 12.71M |